Hypotension from afatinib in epidermal growth factor receptor-mutated non-small cell lung cancer: a case report and literature review

被引：2
|
作者：
Tang, Zhiwei [1 ]
Ji, XiuHai [2 ]
Zhou, Guanghui [1 ]
Chen, Ruhua [1 ]
Fen, Yan [1 ]
Ding, Hui [1 ]
机构：
[1] Jiangsu Univ, Affiliated Yixing Peoples Hosp, Dept Pulm & Crit Care Med, Yixing, Peoples R China
[2] Affiliated Taicang Hosp Tradit Chinese Med, Dept Oncol, Taicang, Peoples R China
来源：
ANTI-CANCER DRUGS | 2022年 / 33卷 / 01期
关键词：
afatinib; epidermal growth factor receptor; hypotension; lung cancer;
D O I：
10.1097/CAD.0000000000001244
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Side effects of afatinib are a problem in patients with advanced non-small cell lung cancer (NSCLC). However, little is known about the occurrence of afatinib-induced hypotension. An 81-year-old man with NSCLC had an epidermal growth factor receptor-positive genotype with the p.L861Q mutation in exon 21. He was administered afatinib (40 mg/day) as anticancer therapy. Hypotension occurred twice after afatinib initiation. He suffered from dizziness and nausea. Blood pressure gradually returned to normal after afatinib cessation. Clinicians should be aware of hypotension in patients with NSCLC after afatinib initiation.
引用
收藏
页码：E840 / E841
页数：2
相关论文
共 50 条
  • [1] Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer-case report
    Mueser, Nino Rafael
    Kirchbacher, Klaus
    Funk, Georg-Christian
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (02) : 107 - 109
  • [2] Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review
    Leonetti, Alessandro
    Minari, Roberta
    Mazzaschi, Giulia
    Gnetti, Letizia
    La Monica, Silvia
    Alfieri, Roberta
    Campanini, Nicoletta
    Verze, Michela
    Olivani, Andrea
    Ventura, Luigi
    Tiseo, Marcello
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Osimertinib a new weapon in epidermal growth factor receptor-mutated non-small cell lung cancer patients
    Rossi, Antonio
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S610 - S613
  • [4] Icotinib combined with rapamycin in a renal transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancer: A case report
    Zhao, Qiong
    Wang, Yina
    Tang, Yemin
    Peng, Ling
    ONCOLOGY LETTERS, 2014, 7 (01) : 171 - 176
  • [5] Treating epidermal growth factor receptor-mutated non-small cell lung cancer-is dacomitinib the winner?
    Dempke, Wolfram C. M.
    Fenchel, Klaus
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 : S88 - S91
  • [6] Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer
    Yu, Qian
    Kobayashi, Susumu S.
    Haeno, Hiroshi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] SHP2 Inhibition Benefits Epidermal Growth Factor Receptor-mutated Non-Small Cell Lung Cancer Therapy
    Xia, Leiming
    Wen, Lu
    Wang, Siying
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (11) : 1314 - 1321
  • [8] Prognostic significance associated with the number of compound mutations in epidermal growth factor receptor-mutated non-small cell lung cancer
    Satoh, Hiroaki
    Sasatani, Yuika
    Miyazaki, Kunihiko
    Sato, Yoshiharu
    Hizawa, Nobuyuki
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2022, 132 (04):
  • [9] Epidermal growth factor receptor-mutated lung adenocarcinoma diagnosed from endometrial polyp metastasis: A case report and literature review
    Bulutay, Pinar
    Bilir, Esra
    Yildiz, Sule
    Ata, Baris
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 19 (01) : 81 - 86
  • [10] Erlotinib Combined with Cyclosporine in a Liver-Transplant Recipient with Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer
    De Pas, Tommaso
    Spitaleri, Gianluca
    Pelosi, Giuseppe
    De Carlis, Luciano
    Lorizzo, Katia
    Locatelli, Marzia
    Curigliano, Giuseppe
    Toffalorio, Francesca
    Catania, Chiara
    De Brand, Filippo
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (01) : 138 - 139
12345